BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 7978535)

  • 21. [Accelerated desensitization for hymenoptera venom allergy in 30 hours: efficacy and safety in 150 cases].
    van der Brempt X; Ledent C; Mairesse M
    Rev Med Brux; 1997 Jun; 18(3):120-4. PubMed ID: 9273600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mastocytosis and insect venom allergy.
    Bonadonna P; Zanotti R; Müller U
    Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):347-53. PubMed ID: 20485157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stinging insect hypersensitivity. Safety and efficacy of venom immunotherapy.
    Golub JR; Kaplan SR; Mascia AV
    N Y State J Med; 1984 Feb; 84(2):66-8. PubMed ID: 6583559
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hyper-accelerated immunotherapy with Hymenoptera venoms].
    Sabbah A; Bonneau JC; Drouet M; Le Sellin J
    Allerg Immunol (Paris); 1987 Apr; 19(4):156-8, 160, 162-3. PubMed ID: 3453132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adverse reactions to venom immunotherapy.
    Ramirez DA; Londono S; Evans R
    Ann Allergy; 1981 Dec; 47(6):435-9. PubMed ID: 7325415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expansion of circulating Foxp3+)D25bright CD4+ T cells during specific venom immunotherapy.
    Pereira-Santos MC; Baptista AP; Melo A; Alves RR; Soares RS; Pedro E; Pereira-Barbosa M; Victorino RM; Sousa AE
    Clin Exp Allergy; 2008 Feb; 38(2):291-7. PubMed ID: 18070166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of venom immunotherapy on serum level of CCL5/RANTES in patients with Hymenoptera venom allergy.
    Gawlik R; Glück J; Jawor B; Rogala B
    Immunopharmacol Immunotoxicol; 2015; 37(4):375-9. PubMed ID: 26181651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and immunologic studies of rapid venom immunotherapy in Hymenoptera-sensitive patients.
    Bernstein DI; Mittman RJ; Kagen SL; Korbee L; Enrione M; Bernstein IL
    J Allergy Clin Immunol; 1989 Dec; 84(6 Pt 1):951-9. PubMed ID: 2480972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of new IgE specificities to hymenoptera allergens during venom-specific immunotherapy.
    Tavares B; Rordigues F; Pereira C; Loureiro G; Chieira C
    Eur Ann Allergy Clin Immunol; 2005 May; 37(5):171-6. PubMed ID: 15984315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis and treatment of allergy to hymenoptera venoms.
    Hamilton RG
    Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):323-9. PubMed ID: 20543672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stinging insect allergy and venom immunotherapy.
    Gupta P; Greenberger PA
    Allergy Asthma Proc; 2004; 25(4 Suppl 1):S9-10. PubMed ID: 15515364
    [No Abstract]   [Full Text] [Related]  

  • 32. [Safety of rush immunotherapy with Hymenoptera venom].
    Sánchez-Morillas L; Reaño Martos M; Rodríguez Mosquera M; Iglesias Cadarso A; Domínguez Lázaro AR
    Allergol Immunopathol (Madr); 2005; 33(4):224-7. PubMed ID: 16045862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes of allergy to insect stings in children, with and without venom immunotherapy.
    Golden DB; Kagey-Sobotka A; Norman PS; Hamilton RG; Lichtenstein LM
    N Engl J Med; 2004 Aug; 351(7):668-74. PubMed ID: 15306668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis.
    González de Olano D; Alvarez-Twose I; Esteban-López MI; Sánchez-Muñoz L; de Durana MD; Vega A; García-Montero A; González-Mancebo E; Belver T; Herrero-Gil MD; Fernández-Rivas M; Orfao A; de la Hoz B; Castells MC; Escribano L
    J Allergy Clin Immunol; 2008 Feb; 121(2):519-26. PubMed ID: 18177694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific immunotherapy in honeybee venom allergy: a comparative study using aqueous and aluminium hydroxide adsorbed preparations.
    Ruëff F; Wolf H; Schnitker J; Ring J; Przybilla B
    Allergy; 2004 Jun; 59(6):589-95. PubMed ID: 15147443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic reactions during maintenance immunotherapy with honey bee venom.
    Bousquet J; Ménardo JL; Velasquez G; Michel FB
    Ann Allergy; 1988 Jul; 61(1):63-8. PubMed ID: 3389573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A controlled trial of immunotherapy in insect hypersensitivity.
    Hunt KJ; Valentine MD; Sobotka AK; Benton AW; Amodio FJ; Lichtenstein LM
    N Engl J Med; 1978 Jul; 299(4):157-61. PubMed ID: 78446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of rush immunotherapy (RIT) on Hymenoptera allergy].
    Hirata H; Yukawa T; Arima M; Yamada G; Makino S; Fukuda T
    Arerugi; 1999 Dec; 48(12):1331-6. PubMed ID: 10666921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical and biological surveillance after the cessation of Hymenoptera venom desensitization].
    Touraine F; Talayrach D; Florea O; Brianchon Ch; Preux PM; Bonnaud F
    Eur Ann Allergy Clin Immunol; 2003 Nov; 35(9):335-9. PubMed ID: 14716961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maintenance venom immunotherapy administered at a 3-month interval preserves safety and efficacy and improves adherence.
    Cavallucci E; Ramondo S; Renzetti A; Turi MC; Di Claudio F; Braga M; Incorvaia C; Schiavone C; Ballone E; Di Gioacchino M
    J Investig Allergol Clin Immunol; 2010; 20(1):63-8. PubMed ID: 20232775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.